How can modeling best contribute to the assessment of secondary stroke prevention strategies?
Publication
, Journal Article
Matchar, DB; Samsa, GP
Published in: Am J Med
February 2005
Duke Scholars
Published In
Am J Med
DOI
ISSN
0002-9343
Publication Date
February 2005
Volume
118
Issue
2
Start / End Page
198 / 199
Location
United States
Related Subject Headings
- Stroke
- Quality-Adjusted Life Years
- Platelet Aggregation Inhibitors
- Models, Theoretical
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Endpoint Determination
- Cost-Benefit Analysis
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Matchar, D. B., & Samsa, G. P. (2005). How can modeling best contribute to the assessment of secondary stroke prevention strategies? Am J Med, 118(2), 198–199. https://doi.org/10.1016/j.amjmed.2004.08.026
Matchar, David B., and Gregory P. Samsa. “How can modeling best contribute to the assessment of secondary stroke prevention strategies?” Am J Med 118, no. 2 (February 2005): 198–99. https://doi.org/10.1016/j.amjmed.2004.08.026.
Matchar DB, Samsa GP. How can modeling best contribute to the assessment of secondary stroke prevention strategies? Am J Med. 2005 Feb;118(2):198–9.
Matchar, David B., and Gregory P. Samsa. “How can modeling best contribute to the assessment of secondary stroke prevention strategies?” Am J Med, vol. 118, no. 2, Feb. 2005, pp. 198–99. Pubmed, doi:10.1016/j.amjmed.2004.08.026.
Matchar DB, Samsa GP. How can modeling best contribute to the assessment of secondary stroke prevention strategies? Am J Med. 2005 Feb;118(2):198–199.
Published In
Am J Med
DOI
ISSN
0002-9343
Publication Date
February 2005
Volume
118
Issue
2
Start / End Page
198 / 199
Location
United States
Related Subject Headings
- Stroke
- Quality-Adjusted Life Years
- Platelet Aggregation Inhibitors
- Models, Theoretical
- Humans
- General & Internal Medicine
- Fibrinolytic Agents
- Endpoint Determination
- Cost-Benefit Analysis
- 42 Health sciences